CHRISTINA NARANJO: Open Payments
NPI 1306314059 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,126 in 36 payments from 12 companies in 2025. Trend: 2023 $1,960 · 2024 $1,139 · 2025 $1,126
Food & beverage: $1,114Education: $12
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $267 |
| Journey Medical Corporation | 2 | $212 |
| Incyte Corporation | 10 | $191 |
| Almirall LLC | 3 | $139 |
| Biofrontera Inc. | 4 | $88 |
| PFIZER INC. | 2 | $75 |
| Amgen Inc. | 2 | $40 |
| REVANCE THERAPEUTICS, INC. | 2 | $37 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $24 |
| Botanix SB Inc | 1 | $24 |
Products named: OPZELURA, Klisyri, EMROSI, NATRELLE SALINE-FILLED BREAST IMPLANTS, LITFULO, OTEZLA, DAXXIFY, SKYRIZI.
Industry payments across CA — which companies pay providers there.
